Designed by: PepsiCo Design & Innovation
Country: United States

Levitra

Updated on November 17th, 2010  |  
1 Minute Read

Levitra

Designed by Burgopak | Country: United Kingdom

“Thomas Proske, Global Brand manager for Levitra® at Bayer Healthcare says: “We chose the Burgopak design for our new Levitra formulation because it’s pocket-friendly, discreet and gives the product a playful edge over its competitors.  While it is patient safe and compliant, it also looks stylish and will appeal to our customers.”

With its packaging for Levitra® 10 mg ODT, Burgopak continues to strengthen its presence in the pharmaceutical industry

Tim Clarke, CEO of Burgopak Healthcare & Technology says: “The innovative packaging design adds significant value to the brand as it’s slick, unique, and appealing to consumers, while supporting patient safety and compliance. In a highly competitive market, it offers differentiation and we’re delighted to continue working with Bayer.”

Popular designs

Yogamood Aromatherapy Body Oils

Designed by Wunsch | Country: Denmark “A newly established yoga studio, Yogamood seeks to place yoga in a modern Scandinavian context, making

Cafaggio

Designed by OlssønBarbieri | Country: Norway “Cafaggio is a traditional Tuscan wine property from the Chianti area. We designed a 3 liter Bag in

Nestlé Easter

Designed by FutureBrand | Illustration: Cako Martin | Country: Brazil FutureBrand commissioned Brazilian illustrator Cako Martin to illustrate these chocolate egg filled metal cans for Nestlé

Designed by: PepsiCo Design & Innovation
Country: United States

Levitra

1 Minute Read
levitra

Levitra

Designed by Burgopak | Country: United Kingdom

“Thomas Proske, Global Brand manager for Levitra® at Bayer Healthcare says: “We chose the Burgopak design for our new Levitra formulation because it’s pocket-friendly, discreet and gives the product a playful edge over its competitors.  While it is patient safe and compliant, it also looks stylish and will appeal to our customers.”

With its packaging for Levitra® 10 mg ODT, Burgopak continues to strengthen its presence in the pharmaceutical industry

Tim Clarke, CEO of Burgopak Healthcare & Technology says: “The innovative packaging design adds significant value to the brand as it’s slick, unique, and appealing to consumers, while supporting patient safety and compliance. In a highly competitive market, it offers differentiation and we’re delighted to continue working with Bayer.”

Previous
Next